1992 Chittagong University, Bangladesh BSc (Hons) Chemistry

1994 Chittagong University, Bangladesh MSc Inorganic Chemistry

1999 Niigata University of Pharmacy, Japan PhD Pharmaceutical Science



1999-2000 Niigata University of Pharmacy, Japan.

2000-2005 New York University (NYU) School of Medicine, New York.



1995-1997 Student fellowship of AIEJ (Association of International Education in Japan)

1997-1999 Student fellowship of Niigata University of Pharmacy



American Association for Cancer Research

Society for Free Radical Biology and Medicine



Graduate School "niigata University of Pharmacy, Niigata, Japan" , Pharmaceutical Science
Graduate School "chittagong University, Chittagong, Bangladesh" , Chemistry

Research Interest

  • Angiogenesis
  • Cyclooxygenase 2
  • GBM invasion
  • Hypoxia and and hypoxia inducible factor


Featured Publications LegendFeatured Publications

SNS-032 prevents tumor cell induced angiogenesis by inhibition vascular endothelial growth factor.
Ali MA, Choy H, Habib AA and Saha D. Neoplasia May 2007 9 370-381
Hypoxia-Inducible Factor 1 and VEGF upregulate CXCR4 in Glioblastoma: Implication for Angiogenesis.
Zagzag D, Lan L, Ali MA, Schnee T, Lukyanov E, Yee H, Newcomb EW. Laboratory Investigation December 2006 86 1221-1232
Noscapine inhibits hypoxia mediated HIF-1a expression and angiogenesis in vitro.
Newcomb EW, Lukyanov E, Schnee T, Ali MA Lan L and Zagzag D International Journal of Oncology May 2006 28 1121-1130
The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells
Mukhopadhyay P, Ali MA, Nandi A, Carreon P, Choy H and Saha D Cancer Research February 2006 66 1758-1766
Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1 expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy
Newcomb EW, Ali MA, Schnee T, Lan L, Lukyanov Y, Fowkes M, Miller DC, Zagzag D Neuro Oncology July 2005 7 225-235